scholarly journals BOOK REVIEWS: Focal Epilepsy: Clinical Use of Emission Tomography (Current Problems in Epilepsy No. 7)

1991 ◽  
Vol 54 (6) ◽  
pp. 565-566
Author(s):  
R. Greenhall
Epilepsia ◽  
2021 ◽  
Author(s):  
Ali K. Vibholm ◽  
Martin J. Dietz ◽  
Sándor Beniczky ◽  
Jakob Christensen ◽  
Andreas Højlund ◽  
...  

Author(s):  
PM Lobbezoo ◽  
L Nobili ◽  
S Gibbs

Background: Sleep-related hypermotor epilepsy (SHE) is a focal epilepsy characterized by abrupt sleep-related hypermotor seizures (SRHS) with complex semiology. Although difficult to localize within the frontal lobe recent studies using intracerebral EEG recordings have suggested the existence of four distinct semiology patterns (SP) organized in a rostro-caudal manner. It remains unclear however if these SP are clinically useful. Methods: We aimed to estimate the inter-rater reliability (IR) of classifying SP in SHE amongst epilepsy and sleep medicine experts. Following a short training session, ten experts were asked to review and classify 40 videos of SRHS in patients with confirmed SHE. IR was calculated using Kappa statistics. Results: SP1 and SP4, who are at the opposite ends of the SHE semiology spectrum, had substantial IR (0.82 and 0.67, respectively). Meanwhile, SP2 and SP3 showed fair agreement (0.25 and 0.35, respectively) and represented the major source of variance, with a small difference favouring epilepsy experts. Conclusions: Amongst epilepsy and sleep medicine experts, IR of classifying SRHS into four SP was only mildly satisfactory. SP1 and SP4 were shown to be easily recognizable while SP2 and SP3 were frequently confounded. Improvements in SP recognition are needed before widespread clinical use.


2010 ◽  
Vol 11 (4) ◽  
pp. 395-399 ◽  
Author(s):  
Hatem Y. El-Bawab ◽  
Mohei M. Abouzied ◽  
Mohammed A. Rafay ◽  
Waseem M. Hajjar ◽  
Waleed M. Saleh ◽  
...  

2006 ◽  
Vol 22 (2) ◽  
pp. 143-148 ◽  
Author(s):  
John Hastings ◽  
Elizabeth J. Adams

Objectives: The International Network of Agencies for Health Technology Assessment (INAHTA) has been tracking activities associated with the clinical use of positron emission tomography (PET) in its members' healthcare systems since 1997 and published its first Joint Project report on PET in 1999. Part 1 of this Joint Project report presents survey results on diffusion, assessment activities, and policy for clinical use related to PET among INAHTA members since 1999.Methods: INAHTA members were surveyed in 2003–2004.Results: Twenty-seven INAHTA agencies (69 percent response rate) from nineteen countries responded to the survey. Dedicated PET systems are the most universally installed systems to date. Mobile scanners and modified gamma cameras are used occasionally as lower cost alternatives, and interest in PET–computed tomography hybrid models is rising despite limited assessment of impact on service planning. PET was used and assessed most commonly for managing patients with cancer. All respondents reported having some form of public funding for clinical PET frequently linked to data collection for the purpose of gathering evidence to refine clinical use and guide resource allocation toward indications that maximize clinical and cost-effectiveness.Conclusions: The use of HTA within a continuous quality improvement framework can help optimize scarce resources for evaluation and use of high cost diagnostic technologies such as PET, particularly where potential clinical or cost-effectiveness is considerable but conclusive evidence is lacking.


Sign in / Sign up

Export Citation Format

Share Document